Heike Monange

The team that delivers

Merck KGaA, Darmstadt, Germany's
BioReliance® End-to-End Solutions has the expertise and flexibility to support accelerated development and commercialization of biologics. With experience developing more than 250 biologics, the team can tailor analytical packages with validated quality attributes and flexibility to support companies in the development of molecules at all stages.

The analytical development and optimization team works closely with our process development and manufacturing teams to reduce uncertainty and mitigate risk at the very early stage of development so that to ensure the success. The strength of our analytical team lies in an open mindset and expertise to tailor programs fitting needs of the company and the pipeline asset.

CDMO: Afraid of tech transfer? There’s no need!

Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable molecule, biotechs need…

A Streamlined Approach to Analytical Method Development and Implementation

The development and implementation of analytical methods are essential for success at all phases of a molecule’s journey,…

Scroll to Top